[go: up one dir, main page]

NO20080080L - Organiske forbindelser - Google Patents

Organiske forbindelser

Info

Publication number
NO20080080L
NO20080080L NO20080080A NO20080080A NO20080080L NO 20080080 L NO20080080 L NO 20080080L NO 20080080 A NO20080080 A NO 20080080A NO 20080080 A NO20080080 A NO 20080080A NO 20080080 L NO20080080 L NO 20080080L
Authority
NO
Norway
Prior art keywords
compound
organic compounds
relates
novel process
formula
Prior art date
Application number
NO20080080A
Other languages
English (en)
Norwegian (no)
Inventor
Gottfried Sedelmeier
Walter Prikoszovich
Hans Hirt
Frank Schafer
Stuart John Mickel
Michael Foulkes
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20080080L publication Critical patent/NO20080080L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20080080A 2005-06-08 2008-01-04 Organiske forbindelser NO20080080L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0511686.8A GB0511686D0 (en) 2005-06-08 2005-06-08 Organic compounds
PCT/EP2006/005370 WO2006131304A2 (en) 2005-06-08 2006-06-06 Process for preparing renin inhibitors

Publications (1)

Publication Number Publication Date
NO20080080L true NO20080080L (no) 2008-01-04

Family

ID=34835327

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080080A NO20080080L (no) 2005-06-08 2008-01-04 Organiske forbindelser

Country Status (24)

Country Link
US (2) US7767831B2 (ru)
EP (2) EP2080754A3 (ru)
JP (2) JP2008542415A (ru)
KR (1) KR20080014011A (ru)
CN (1) CN101193860B (ru)
AR (1) AR054374A1 (ru)
AU (1) AU2006256938B2 (ru)
BR (1) BRPI0611919A2 (ru)
CA (1) CA2608575A1 (ru)
EC (1) ECSP077986A (ru)
GB (1) GB0511686D0 (ru)
GT (1) GT200600208A (ru)
IL (1) IL187004A0 (ru)
MA (1) MA29563B1 (ru)
MX (1) MX2007015418A (ru)
NO (1) NO20080080L (ru)
NZ (2) NZ562889A (ru)
PE (2) PE20070075A1 (ru)
RU (1) RU2418785C2 (ru)
SG (1) SG155209A1 (ru)
TN (1) TNSN07465A1 (ru)
TW (1) TW200716544A (ru)
WO (1) WO2006131304A2 (ru)
ZA (1) ZA200709076B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0521083D0 (en) 2005-10-17 2005-11-23 Novartis Ag Organic compounds
DE102007049039A1 (de) 2007-10-11 2009-04-16 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
EP2225200B1 (en) 2007-12-24 2013-10-16 DSM IP Assets B.V. Convergent synthesis of renin inhibitors and intermediates useful therein
SI2189442T1 (sl) 2008-11-20 2015-03-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek in intermediati za pripravo aliskirena
EP2464623B1 (en) 2009-08-11 2020-11-04 Novartis AG The ring opening of lactones and lactams
US8203005B2 (en) 2009-10-29 2012-06-19 Carbo Design Llc Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren
EP2523934A1 (en) * 2010-02-10 2012-11-21 Ratiopharm GmbH Salts of aliskiren
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren
CN111423325A (zh) * 2020-04-26 2020-07-17 江苏凯迪恩医药科技有限公司 基于蒽醌类药物的双醋瑞因合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570108A (en) * 1982-07-06 1986-02-11 Stroede Aake Protection device for electrical incandescent lamps
US5659065A (en) 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5606078A (en) 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
CA2121898A1 (en) * 1994-04-21 1995-10-22 Stephen Hanessian Synthesis of prototypes for renin inhibitors
IT1292426B1 (it) * 1997-06-27 1999-02-08 Nicox Sa Sali nitrati di ace-inibitori
JP2005231999A (ja) * 2000-03-08 2005-09-02 Banyu Pharmaceut Co Ltd カルバペネム誘導体の製造方法
PL212898B1 (pl) 2000-07-05 2012-12-31 Speedel Pharma Ag Sposób otrzymywania podstawionych amidów oktanoilowych oraz zwiazki posrednie wykorzystane w tym sposobie
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
ATE342887T1 (de) * 2000-12-14 2006-11-15 Speedel Pharma Ag Verfahren zur herstellung von aryloctanoyl-amiden
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ZA200709076B (en) 2008-10-29
WO2006131304A2 (en) 2006-12-14
IL187004A0 (en) 2008-02-09
CA2608575A1 (en) 2006-12-14
PE20070075A1 (es) 2007-03-16
WO2006131304A3 (en) 2007-07-19
CN101193860B (zh) 2013-01-02
KR20080014011A (ko) 2008-02-13
RU2418785C2 (ru) 2011-05-20
TW200716544A (en) 2007-05-01
NZ591010A (en) 2012-06-29
CN101193860A (zh) 2008-06-04
BRPI0611919A2 (pt) 2010-10-05
NZ562889A (en) 2011-11-25
JP2013028607A (ja) 2013-02-07
US7767831B2 (en) 2010-08-03
AU2006256938A1 (en) 2006-12-14
AU2006256938B2 (en) 2009-12-17
RU2007148226A (ru) 2009-07-20
EP2080754A3 (en) 2010-06-02
AR054374A1 (es) 2007-06-20
EP1896411A2 (en) 2008-03-12
JP2008542415A (ja) 2008-11-27
PE20091359A1 (es) 2009-10-13
US20100274027A1 (en) 2010-10-28
TNSN07465A1 (en) 2009-03-17
ECSP077986A (es) 2008-01-23
MX2007015418A (es) 2008-02-21
US20080207921A1 (en) 2008-08-28
GT200600208A (es) 2007-03-28
SG155209A1 (en) 2009-09-30
EP2080754A2 (en) 2009-07-22
GB0511686D0 (en) 2005-07-13
MA29563B1 (fr) 2008-06-02

Similar Documents

Publication Publication Date Title
NO20080080L (no) Organiske forbindelser
NO20082263L (no) Organiske forbindelser
WO2007091009A3 (en) Preparation of delmopinol
EA200501061A1 (ru) N-(1-бензил-2-оксо-2-(1-пиперазинил)этил)-1-пиперидинкарбоксамидные производные и родственные соединения в качестве cgrp-антагонистов для лечения головных болей
NO20092692L (no) MAPK/ERK kinaseinhibitorer
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
TN2009000401A1 (en) New methods
WO2009127948A8 (en) 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
NO20082005L (no) Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon
NO20082116L (no) Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse
WO2008155338A3 (en) Process for the synthesis of intermediates of renin inhibitors such as aliskiren
BRPI0408160B1 (pt) Processo para o preparo de ésteres do ácido nicotínico substituído e intermediários de enamina para uso nesse processo
NO20075618L (no) Novel compounds as GLP-1 Agonists
Li et al. Synthesis and antibacterial activities of yanglingmycin analogues
WO2008103367A3 (en) Method for assembling high-purity chemical libraries, proapoptotic compounds discovered by same
NO20081859L (no) Fremgangsmate for fremstillingen av sartanderivater og mellomprodukter som er nyttige i slike fremgangsmater
AU2002367103A1 (en) An improved synthesis of ceftiofur intermediate
NO20073602L (no) Fremgangsmate for fremstilling av hoyrent meloksikam og meloksikamkaliumsalt
NO20076307L (no) Fremgangsmater for a fremstille biarylurinstoffer og analoger derav
WO2007054784A8 (en) An improved process for the preparation of granisetron hydrochloride
Styring et al. Stereoselective synthesis of a thiazolane amide using molecular recognition in the triazolyl-activated ester intermediate
WO2009040755A3 (en) Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto
WO2004091549A3 (en) Process for making alpha-substituted hydroxamic acids
DE602006003227D1 (de) Verfahren zur gewinnung der pharmazeutisch aktivendavon und verfahren zu deren gewinnung
TH78688A (th) กรรมวิธีสำหรับการเตรียมไพราโซล

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application